Chris Cline | SVP, IR & Corporate Communications |
Dr. Eric Dube | CEO |
Dr. Noah Rosenberg | Chief Medical Officer |
Peter Heerma | Chief Commercial Officer |
Laura Clague | CFO |
Dr. Bill Rote | SVP, Research and Development |
Joseph Schwartz | SVB Leerink |
Liisa Bayko | Evercore ISI |
Tim Lugo | William Blair |
Greg Harrison | Bank of America |
Michelle Gilson | Canaccord |
Maury Raycroft | Jefferies |
Laura Chico | Wedbush Securities |
Good afternoon, ladies and gentlemen, and welcome to the Travere Therapeutics Second Quarter 2021 Financial Results and Corporate Update Call. At this time, all participants are in a listen-only mode. Later, we will conduct question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Mr.